SPP2
Basic information
Region (hg38): 2:234050679-234077134
Links
Phenotypes
GenCC
Source:
- retinitis pigmentosa (Limited), mode of inheritance: AD
- retinitis pigmentosa (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (178 variants)
- not_specified (28 variants)
- Retinal_dystrophy (15 variants)
- SPP2-related_disorder (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPP2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006944.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 35 | 37 | ||||
| missense | 82 | 11 | 96 | |||
| nonsense | 6 | |||||
| start loss | 0 | |||||
| frameshift | 4 | |||||
| splice donor/acceptor (+/-2bp) | 8 | |||||
| Total | 0 | 2 | 100 | 46 | 3 |
Highest pathogenic variant AF is 6.8409184e-7
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SPP2 | protein_coding | protein_coding | ENST00000168148 | 7 | 26456 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.69e-14 | 0.00202 | 125707 | 0 | 40 | 125747 | 0.000159 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.389 | 136 | 124 | 1.10 | 0.00000691 | 1398 |
| Missense in Polyphen | 35 | 31.191 | 1.1221 | 369 | ||
| Synonymous | 0.00698 | 44 | 44.1 | 0.999 | 0.00000263 | 362 |
| Loss of Function | -1.37 | 18 | 12.7 | 1.41 | 5.35e-7 | 160 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000630 | 0.000630 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000185 | 0.000185 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.0000654 | 0.0000653 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Could coordinate an aspect of bone turnover. {ECO:0000250}.;
- Pathway
- Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis
(Consensus)
Intolerance Scores
- loftool
- 0.814
- rvis_EVS
- -0.32
- rvis_percentile_EVS
- 31.69
Haploinsufficiency Scores
- pHI
- 0.0358
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.421
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.00449
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Spp2
- Phenotype
Gene ontology
- Biological process
- skeletal system development;platelet degranulation;negative regulation of endopeptidase activity;post-translational protein modification;cellular protein metabolic process;bone remodeling
- Cellular component
- extracellular region;endoplasmic reticulum lumen;platelet dense granule lumen;collagen-containing extracellular matrix
- Molecular function
- endopeptidase inhibitor activity